News

Published on 25 Nov 2024 on Zacks · via Yahoo Finance

Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?


Article preview image

Utilizing ratios like P/E, PEG, Price/Sales...Flow, the Value Style Score identifies the most...

NASDAQ.EXEL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?

Utilizing ratios like P/E, PEG, Price/Sales...Flow, the Value Style Score identifies the most...

Zacks · via Yahoo Finance 25 Nov 2024

Exelixis Stock Surges 25% in a Month: Time to Buy or Sell?

EXEL's shares move north 25% in a month on the back of strong third-quarter results and raised...

Zacks · via Yahoo Finance 25 Nov 2024

3 TSX Penny Stocks With Market Caps Over CA$30M

Over the last 7 days, the Canadian market has remained flat, but it is up 22% over the past year ...

Simply Wall St. · via Yahoo Finance 21 Nov 2024

Should iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV) Be on Your Investing...

The ETF has added roughly 21.68% so far this year and...about 294 holdings, it effectively...

Zacks · via Yahoo Finance 21 Nov 2024

Zacks.com featured highlights Amazon, Maplebear, Exelixis and Doximity

In this regard, we ran a screener that yielded stocks Amazon.com, Maplebear Inc., Exelixis and...

Zacks · via Yahoo Finance 20 Nov 2024

Exelixis, Inc. (EXEL): Among Hedge Funds’ Top Biotech Stock Picks

We recently compiled a list of the 10 Largest Biotech Hedge Funds and Their Top Stock Picks. In t...

Insider Monkey · via Yahoo Finance 24 Sep 2024

Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript

Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript April 30, 2024 Exelixis, Inc. misse...

Insider Monkey via Yahoo Finance 2 May 2024

Exelixis (EXEL) Q1 Earnings Miss, Cabometyx Sales Fall Short

Exelixis, Inc. EXEL reported lower-than-expected results for the first quarter. Its shares fell 7...

Zacks via Yahoo Finance 1 May 2024

Exelixis Inc (EXEL) Q1 2024 Earnings: Mixed Results Amidst Restructuring Efforts

Total Revenue: Reported at $425.2 million for Q1 2024, showing an increase from $408.8 million in...

GuruFocus.com via Yahoo Finance 30 Apr 2024

Collegium (COLL) to Report Q1 Earnings: Here's What to Expect

Investors are expected to focus on top and bottom-line growth when Collegium Pharmaceutical COLL ...

Zacks via Yahoo Finance 29 Apr 2024